公告 Merrimack Pharmaceuticals Inc|Contract Adjustment

发表于 2024-05-17 00:00   81次浏览

公告 Quarterly report [Sections 13 or 15(d)]

发表于 2024-05-16 05:07   296次浏览

公告 Current report, items 5.07, 7.01, and 9.01

发表于 2024-05-11 04:51   275次浏览

公告 Notification of the removal from listing and registration of matured, redeemed

发表于 2024-05-11 04:50   260次浏览

公告 Current report, items 7.01 and 9.01

发表于 2024-05-09 19:52   234次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2024-05-09 19:52   236次浏览

公告 Merrimack Pharmaceuticals Inc|Contract Adjustment

发表于 2024-05-08 00:00   89次浏览

公告 Current report, items 3.01, 7.01, and 9.01

发表于 2024-05-01 05:57   193次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2024-05-01 05:57   178次浏览

公告 Revised definitive proxy soliciting materials

发表于 2024-04-02 04:47   179次浏览

公告 Current report, items 7.01 and 9.01

发表于 2024-03-28 05:29   143次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2024-03-28 05:28   148次浏览

公告 Additional definitive proxy soliciting materials and Rule 14(a)(12) material

发表于 2024-03-22 22:19   128次浏览

公告 Other definitive proxy statements

发表于 2024-03-22 05:18   150次浏览

公告 [Amend] Annual report [Section 13 and 15(d), not S-K Item 405]

发表于 2024-03-22 05:00   143次浏览

公告 Prospectuses and communications, business combinations

发表于 2024-03-08 06:26   192次浏览

公告 Current report, items 7.01 and 9.01

发表于 2024-03-08 06:23   190次浏览

公告 Annual report [Section 13 and 15(d), not S-K Item 405]

发表于 2024-03-08 05:26   187次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2024-03-08 02:06   187次浏览

公告 Other preliminary proxy statements

发表于 2024-03-06 11:37   209次浏览